A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2
150
about 1.6 years
18+
36 sites in AL, AZ, CA +15
What this study is about
This trial is testing a treatment called LY4065967 for people with diabetic peripheral neuropathic pain. The goal is to see if this treatment is safe and effective.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take LY4065967
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change from Baseline in Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)
Secondary: Change From Baseline in the Brief Pain Inventory-Short Form Modified (BPI-SFM) Total Pain Interference Score, Change from Baseline in Emotional Functioning as Measured by the EuroQol-5D 5 Level Questionnaire (EQ 5D 5L), Change from Baseline in Overall Improvement as Measured by Patient's Global Impression of Change (PGI-C), Change from Baseline in Sleep Scale from the Medical Outcomes Study (MOS Sleep Scale), Change from Baseline in Worst Pain Intensity as Measured by NRS